Huntsman Carole — SEC Form 4 filings
SEC reporting owner CIK 2001571. 8 Form 4 filings on record with FilingPulse; latest filed 2026-03-06.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-01-25 to 2026-03-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 25 legs across 6 filings — 6,156 shares, $2,645,517 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 894 shares @ $550.97 ($492,567) in MADRIGAL PHARMACEUTICALS, INC., filed 2025-11-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Chief Commercial Officer | 8 | — | 25 legs · 6,156 sh · $2,645,517 | 7 |
Form 4 filings — Huntsman Carole
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-06 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 3,989 @ $0 · Sale (S): 419 @ $431.94 · Grant/award (A): 4,986 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 340 @ $492.42 · Sale (S): 570 @ $494.59 | EDGAR |
| 2025-11-21 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 894 @ $550.97 · Sale (S): 144 @ $547.27 · Sale (S): 120 @ $548.71 · Sale (S): 40 @ $549.34 · Sale (S): 200 @ $552.38 · Sale (S): 40 @ $553.23 · +5 more | EDGAR |
| 2025-03-07 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 3,386 @ $0 · Grant/award (A): 5,703 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 71 @ $313.08 · Sale (S): 200 @ $314.74 · Sale (S): 300 @ $320.21 · Sale (S): 200 @ $323.65 · Sale (S): 200 @ $324.59 · Sale (S): 100 @ $326.34 · +3 more | EDGAR |
| 2025-01-27 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 347 @ $335.24 | EDGAR |
| 2024-11-22 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 688 @ $316.92 | EDGAR |
| 2024-01-25 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 3,639 @ $0 · Grant/award (A): 5,483 (derivative) @ $0 · Grant/award (A): 3,639 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2001571 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →